1. Home
  2. CZFS vs PLYX Comparison

CZFS vs PLYX Comparison

Compare CZFS & PLYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Citizens Financial Services Inc.

CZFS

Citizens Financial Services Inc.

HOLD

Current Price

$66.58

Market Cap

288.7M

Sector

Finance

ML Signal

HOLD

PLYX

Polaryx Therapeutics Inc. Common Stock

N/A

Current Price

$4.96

Market Cap

271.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CZFS
PLYX
Founded
1984
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
288.7M
271.8M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
CZFS
PLYX
Price
$66.58
$4.96
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$10.00
AVG Volume (30 Days)
6.1K
307.0K
Earning Date
04-30-2026
05-22-2026
Dividend Yield
3.07%
N/A
EPS Growth
30.26
N/A
EPS
7.62
N/A
Revenue
$9,881,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.64
N/A
P/E Ratio
$8.74
N/A
Revenue Growth
2.82
N/A
52 Week Low
$49.99
$2.20
52 Week High
$69.58
$9.18

Technical Indicators

Market Signals
Indicator
CZFS
PLYX
Relative Strength Index (RSI) 50.81 40.91
Support Level $53.79 $2.37
Resistance Level $68.87 $5.05
Average True Range (ATR) 1.92 0.65
MACD -0.15 -0.21
Stochastic Oscillator 19.51 0.22

Price Performance

Historical Comparison
CZFS
PLYX

About CZFS Citizens Financial Services Inc.

Citizens Financial Services Inc is a Pennsylvania-chartered bank and trust company. The company through its banking subsidiary provides banking activities and services for individual, business, governmental and institutional customers. Its activities and services principally include checking, savings, and time deposit accounts; residential, commercial and agricultural real estate, commercial and industrial, state and political subdivision and consumer loans; and a variety of other specialized financial services. The Trust and Investment division of the Bank offers a full range of client investment, estate, mineral management, and retirement services.

About PLYX Polaryx Therapeutics Inc. Common Stock

Polaryx Therapeutics Inc is a clinical-stage biotechnology company committed to the discovery, development, and commercialization of novel, disease-modifying therapies for rare, pediatric LSDs. Its therapeutic approach focuses on treating the underlying pathophysiology of these diseases and addressing unmet needs. The company's therapeutic pipeline includes PLX-200, PLX-300, and PLX-100, which are orally available small-molecule drug candidates designed to address core pathological mechanisms common to LSDs. The Company has one reportable segment: lysosomal storage disorders. The lysosomal storage disorders segment consists of the Company's costs associated with the preclinical and clinical development of the Company's product candidates.

Share on Social Networks: